01 8Acthar
Main Therapeutic Indication : Immunology
Currency : USD
2020 Revenue in Millions : 768
2019 Revenue in Millions : 953
Growth (%) : -19
Main Therapeutic Indication : Immunology
Currency : USD
2021 Revenue in Millions : 594
2020 Revenue in Millions : 768
Growth (%) : -23
Main Therapeutic Indication : Immunology
Currency : USD
2022 Revenue in Millions : 516
2021 Revenue in Millions : 594
Growth (%) : -13
Main Therapeutic Indication : Immunology
Currency : USD
2023 Revenue in Millions : 425
2022 Revenue in Millions : 516
Growth (%) : -18
Main Therapeutic Indication : Autoimmune Disorders
Currency : USD
2016 Revenue in Millions : 1,160
2015 Revenue in Millions : 1,037
Growth (%) : 12
Main Therapeutic Indication : Autoimmune Disorders
Currency : USD
2017 Revenue in Millions : 1,195
2016 Revenue in Millions : 1,486
Growth (%) : -20
Main Therapeutic Indication : Autoimmune Disorders
Currency : USD
2018 Revenue in Millions : 1,110
2017 Revenue in Millions : 1,195
Growth (%) : -7%
Main Therapeutic Indication : Immunology
Currency : USD
2019 Revenue in Millions : 953
2018 Revenue in Millions : 1,110
Growth (%) : -14
LOOKING FOR A SUPPLIER?
